Can AI improve healthcare for everyone?
Will the introduction of AI systems improve diagnosis, treatment, and research, bringing better and fairer healthcare to all? Or not?...
Will the introduction of AI systems improve diagnosis, treatment, and research, bringing better and fairer healthcare to all? Or not?...
Restrictive eligibility criteria has been a concern for many oncology researchers, who believe these trials should reflect a broader real-world population....
Dr. Jill Biden participated in a listening session at the Foundation for Black Women’s Wellness on Madison’s West Side where she and U.S. Sen. Tammy Baldwin spoke on a panel with many of Madison and Milwaukee’s community health leaders highlighting the importance of early detection and...
To fully appreciate the transformative potential of artificial intelligence in health care, one must think globally....
Arabs are are often categorized as white in clinical research. Grouping individuals from diverse genetic backgrounds under a single racial category can be problematic in clinical research....
Sponsors can employ several postmarketing strategies to beef up safety and efficacy data on populations that were under-represented in initial clinical trials of drugs and biologics, according to new draft guidance issued by the US Food and Drug Administration (FDA)....
Principal investigators recognize the need for greater diversity among participants in the clinical trials they run but are frustrated that the inclusion/exclusion criteria handed to them by sponsors often don't match the real-life situations of the average patient in their practice with the condition of...
Americans in ethnic and racial minority groups are underrepresented in Alzheimer's research, a new study finds....
Clinical research must be inclusive of all body types and identities....
A researcher weighs in on the current state of decentralized clinical trials, their potential to increase participant diversity, and what research is still needed to confirm their efficacy....